HIF1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.37499999666824E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
4.42499999975254E-08 |
Normal-vs-Stage2 |
7.63070000520116E-08 |
Normal-vs-Stage3 |
5.2159999652801E-09 |
Normal-vs-Stage4 |
8.36569999940195E-08 |
Stage1-vs-Stage2 |
9.955200E-01 |
Stage1-vs-Stage3 |
3.109600E-02 |
Stage1-vs-Stage4 |
9.662800E-01 |
Stage2-vs-Stage3 |
1.360830E-01 |
Stage2-vs-Stage4 |
9.762400E-01 |
Stage3-vs-Stage4 |
1.847430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.50240000440505E-08 |
Normal-vs-AfricanAmerican |
1.91862999999737E-05 |
Normal-vs-Asian |
1.74139999997713E-06 |
Caucasian-vs-AfricanAmerican |
6.473600E-02 |
Caucasian-vs-Asian |
6.801000E-01 |
AfricanAmerican-vs-Asian |
3.533600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.08789999733838E-08 |
Normal-vs-Female |
3.67239999521374E-08 |
Male-vs-Female |
6.410800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.8795000000793E-07 |
Normal-vs-Age(41-60Yrs) |
8.2055999994779E-08 |
Normal-vs-Age(61-80Yrs) |
1.09759999977754E-08 |
Normal-vs-Age(81-100Yrs) |
1.10289999355473E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.747600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.182000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.556300E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.994500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.098200E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.161600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.938500E-02 |
Normal-vs-Grade 2 |
4.84429999447755E-08 |
Normal-vs-Grade 3 |
1.00529999880195E-08 |
Normal-vs-Grade 4 |
1.82329999987019E-08 |
Grade 1-vs-Grade 2 |
3.413800E-01 |
Grade 1-vs-Grade 3 |
2.384400E-01 |
Grade 1-vs-Grade 4 |
2.583800E-01 |
Grade 2-vs-Grade 3 |
9.850200E-02 |
Grade 2-vs-Grade 4 |
3.360800E-01 |
Grade 3-vs-Grade 4 |
8.359800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
4.69320005080931E-09 |
Normal-vs-ccB subtype |
1.91279999950389E-07 |
ccA subtype-vs-ccB subtype |
2.402700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.17879999994975E-08 |
Normal-vs-N1 |
1.29729999964745E-07 |
N0-vs-N1 |
6.834800E-01 |
|
|